Oncology – Pathway International

Dr. Devender Sharma – Medanta The Medicity

Pathway International — Tue, 21 May 2019 12:25:02 +0000

Associate Consultant, Medanta – The Medicity, Gurugram

SPECIALITY: Oncologist

EXPERIENCE: 11 Years

LANGUAGE: English, Hindi, Arabic, Russian & More

LOCATION: Gurugram

About Dr. Devender Sharma

Dr. Devender Sharma is a medical oncologist with 11 years of experience. He currently works at Medanta-The Medcity with 11 years of experience. He has a Fellowship in Advanced Laparoscopic Surgery from Indian Association of Gastrointestinal Endo-Surgeons, New Delhi, India.

Treatments Performed By Dr. Devender Sharma

Cancer Care

Practice At

Medanta – The Medicity

Sector 38, Gurugram, Haryana 122018

Educational Background

MS – General Surgery ,PGIMS Medical College, Rohtak, 2003
Fellowship – Advanced Laparoscopic Surgery ,Indian Association of Gastrointestinal Endo-Surgeons, New Delhi, India, 2017
MS – General Surgery ,PGIMS Medical College, Rohtak, 2003
MBBS ,PGIMS Medical College, Rohtak

The post Dr. Devender Sharma – Medanta The Medicity appeared first on Pathway International.

Dr. Hari Goyal – Artemis Hospital

Pathway International — Fri, 17 May 2019 07:41:02 +0000

Designation: Chief – Medical Oncology (Unit I)

Specialty: Oncology,Hematology

Location: Gurgaon

Nationality: Indian

Languages spoken: Hindi,English,Punjabi

Gender: Male

Artemis Hospital, Gurgaon

Profile:

Qualifications
MBBS, MD, DM & PDCR

Post Graduate
MD (Internal Medicine), SMS Hospital, Jaipur
DM (Oncology), AIIMS, New Delhi
Junior Registrar, Tata Memorial Centre, Mumbai
Professional Diploma in Clinical Research

Brief Profile
Dr. Hari Goyal had the privilege to work in best of Cancer Centers of India. He started his career in the field of Oncology at Tata Memorial Centre & did the prestigious course of DM from All India Institute of Medical Sciences, New Delhi.

He is the head of Oncology unit comprising eminent doctors like Dr. Deepak Singla, Dr. Mohit Saxena & Dr. Smita B. Choudhury. The team effort gives an edge & advantage to the patients’ management.

His practice has a major influence of teachings of pioneers in oncology, Dr. S.H. Advani, Dr. Vinod Kochupillai & Dr. Lalit Kumar. He has long associations with experts like Dr. P.K. Julka, Dr. Subodh Pandey, Dr. S. Hukku, Dr. Sudhir Bahadur & Dr. K.K. Pandey.

His yesteryear colleagues are now prominent cancer specialists & are heading the cancer department of big institutions across the country and other part of the globe.

His contribution to oncology is immense & has developed drugs for management of chemotherapy side effects. This development has helped millions of cancer patients since 2004. He was a part of large number of clinical trials of cancer research including one of the FDA audited trial. He has many prestigious awards to his credit which reflect his dedication, in- depth knowledge & collaboration with other departments to cure cancer.

Immunotherapy in cancer is evolving very rapidly and a large number of patients are getting significant improvement in quality of life. Experience of these drugs in patients as well as in pivotal international clinical trials has made him one of the forerunners in the quest to control disease through immunotherapy. In depth knowledge & intent of these molecules is immense & it directs him to select patients who can be benefited or not from immunotherapy. Presently he is running clinical trial on drugs like : DURVALUMAB, TREMELIMUMAB, ATEZOLIZUMAB and others.

His communication, truthful discussions about outcome & energetic attitude is the key to his present success. Consistency, punctuality & empathy are some of his qualities which are admired by his patients & colleagues. A hard worker with a positive attitude towards the sick, he deals with all kinds of cancer. He has a passion for cure & control of cancer which make him an exceptional oncologist. His motto is to provide comprehensive & holistic treatment to each & every cancer patient.

An expert of traditional drugs to recent advances, he is a hope, constant support & a friend of cancer patients & their families. He is adored by one & all. He is a versatile personality & a prolific writer. He is an expert of calligraphy & considered as a motivational guru by hundreds.

MEMBERSHIP
Member to many personal, professional & social organisations.

HONOURS AND REWARDS
• Triveni Ratna Award given by Member of Parliament, Shri Mahabal Mishra
• Unnat Bharat Seva given by Union Minister of Agriculture at Parliament Annexe
• Awards at many local functions across the country.

Clinical Focus
• Holistic approach towards cancer patients.
• Try to give cure, control and care by best possible means.

Procedures
All procedures related to the specialty.

Publications
Over 30 National & international publications.

Recent ongoing trials
1. Clinical research associate in protocol 94CE 32 .Phase III comparative study of combination treatment with TLC D99 liposomal doxorubicin and cyclophosphamide and doxorubicin in metastatic breast cancer.

2. A Multicentric, open label phase III clinical trial to evaluate the safety of filgrastim in cancer patients with grade 3 or 4 chemotherapy induced neutropenia.

3. Organizing secretary, 4th international seminar on psychosocial oncology, new delhi ,april 1999.

4. TZ-01-002: A Randomized, Double-Blind, Multicentre, Parallel Group Study Comparing Two Humanized Monoclonal Antibodies that Target HER2 Receptors in combination with weekly Paclitaxel Administered as First-Line Treatment in Patients with HER2- Positive Metastatic Breast Cancer”.

5. SB3-G31-BC: “A Phase III Randomised, Double-Blind, Parallel Group, Multicentre Study to Compare the Efficacy, Safety, Pharmacokinetics and Immunogenicity between SB3 (proposed trastuzumab biosimilar) and Herceptin® in Women with Newly Diagnosed HER2 Positive Early or Locally Advanced Breast Cancer in Neoadjuvant Setting”.

6. A multicentre, randomized, open label, two period, two treatment, two way crossover, comparative bioavailability study at Steady state comparing Capecitabine Extended release Capsule 500mg (Intas Pharmaceuticals Ltd, India) to the reference listed drug Xeloda (Capecitabine 500mg ; Roche Pharmaceuticals) in patients of Breast Cancer or Colorectal cancer under fed condition.

7. A Phase III randomized, open- label, Multi-center, global study of MEDI4736 alone or in combination with Tremelimumab versus standard of Care in the treatment of First-line recurrent or Metastatic Squamous Cell Head & neck cancer patients.

8. A multicenter, open label, balanced, randomized, two treatment, three period, three sequence, reference replicate crossover, single dose, oral bioequivalence study of Capecitabine film coated tablets 500mg of Shilpa Medicare Limited, India & Xeloda film coated tablets 500mg (Capecitabine) marketed by Roche Registration limited, 6 Falcon way, Shire park, Welwyn garden city, AL71 TW United Kingdome following single oral dose of 2000mg (4x500mg) in adult human cancer patients under fed conditions.

The post Dr. Hari Goyal – Artemis Hospital appeared first on Pathway International.

Dr. T.P.S. Bhandari – Apollo Hospitals: Hyderabad

Pathway International — Fri, 17 May 2019 07:02:36 +0000

Consultant
Apollo Health City, Hyderabad

Profile

Dr. Trilok Pratap Singh Bhandari is a General Surgeon and Surgical Oncologist in Jubilee Hills, Hyderabad and has an experience of 18 years in these fields. Dr. Trilok Pratap Singh Bhandari practices at Apollo Hospitals in Jubilee Hills, Hyderabad. He completed MBBS from L.P.S Institute of Cardiology, G.S.V.M Medical College, Kanpur in 1991,MS – General Surgery from King Georges Medical College, Lucknow University in 1995 and DNB – General Surgery from Lady Hardinge Medical College, New Delhi in 1995.

Qualification

MBBS; MS (General Surgery); DNB; FIS (Onc); MCh (Surg Onc), Advanced Onco plastic Breast Surgery

Work Experience

- Indo American Hospital, HyderabadCancer Institute, Adayar, MadrasKGMC, Lucknow
- Assistant Professor, Cancer Institute, Adayar, Chennai, 1999 – 2001
- Chief Registrar, KGMC, Lucknow & Resident, Safdarjung Hospital, New Delhi, 1991 – 2001
- Indo American Hospital, Hyderabad, 2001 – 2002
- Sr. Consultant, Surgical Oncology, Apollo Hospitals, Hyderabad, 2002 – Present

Registration No

84486

Services

Lumpectomy

Gender

Male

Research and Publications

- Principal investigator for celtrion trial, performed advanced robotic colorectal surgery
- Initiated and performed first Limp salvage Surgery Program in Andhar pradesh 2004 to date > 200 Limp salvage Surgeries performed successfully.
- Oncoplastic Breast and Reconstructive surgeon

Professional Memberships

- Indian Society of Oncology
- Member Royal College of Surgeons(London)

Special Interest

- Surgical Oncology

The post Dr. T.P.S. Bhandari – Apollo Hospitals: Hyderabad appeared first on Pathway International.

7 Tips for a Successful First Visit to Your Oncologist

Pathway International — Thu, 10 Jan 2019 06:45:31 +0000

Thus begins the unique relationship between you and your doctor to degrade and destroy the invader within. Military clichés aside, it is often a long campaign, with suffering and retreats, changes in strategies, and hopefully some victories. It pays to get off to a good start, as the faster the treatment commences, the faster you may return to your normal self. The initial consultation with your oncologist is more important than you may realize! Here are some suggestions to help transform your initial visit into a productive relationship.
Artwork by Jon Carter, cartertoons.com

Please bring someone with you, whether it is family, a friend, or even the neighbor who is serving as your chauffeur. It is frightening enough to have to sit in an oncologist’s office; it is unacceptable to have to go through it alone in my opinion. Why not surround yourself with those who care enough to be your advocate, or at least your pal? Do you know what oncologists first think when they walk into a room full of people? “This patient is loved,” followed by “I had better do my best.” I believe that inviting supporters to the consultation fosters patient empowerment and all its advantages. It also helps to have extra pairs of ears available to remember what was discussed

This piece of advice requires work on your part, but I believe it is worth it. You don’t have to lug your entire chart with you, but if you can just get the pathology and radiology reports, you increase the odds that between you and your oncologist the integral pieces of your case will be intact. Also, please call and ask if you should bring CDs of your scans for the doctor to review.

When your life is on the line, there is no such thing as a silly question. You owe it to yourself to ensure that when you leave the office all your concerns have been addressed. Questions tend to appear magically at all hours of the day, so this is why you should record them. Remember to bring your list and get answers! By the way, “I don’t know” is frequently the correct answer to a question, so don’t be discouraged if you hear it.

Maybe you want to tape-record the visit for your kids who live out of town, or maybe someone who can’t be there wants desperately to hear what the oncologist has to say. Remember, your future is at stake—don’t be shy. I personally don’t care if a patient employs the speakerphone, FaceTime, Skype, Bat phone, or Ouija board. One of our principal obligations is to communicate with family, no matter where they are. Maybe a certain treatment you read about has captured your interest and you wonder if it is right for you. Ask away—doctors love to expound on such topics

Trust me on this—the minute you get home the family will ask, 10 fingers poised over the keyboard, Google locked and loaded, “What did the doc recommend?” This is why you should ask your oncologist to give you a paper copy of the plan, including drug information, especially if you are thinking of getting a second opinion. Remember, what makes a second opinion useful is when it is compared to the first. If no one can remember what the first opinion was, it might be a bit challenging to compare the two.

Do not let bias or skepticism contaminate your decision regarding treatment. If you are keen on an alternative therapy, mention it to the doctor. If others have convinced you that all cancer treatments produce horrific side effects, confess your fears. This new era of personalized cancer care that for many produces outstanding results with reduced toxicity requires fairly intensive patient counseling. As we explain why we want you to consider taking a particular treatment, don’t dismiss it without learning all the facts.

You certainly have every right to keep your thoughts to yourself; however, what you withhold from your oncologist may interfere with reaching your goal of being cancer-free. If you are unhappy with us or our staff, please speak out. We would not be in this field if we did not want to improve our skills. If you feel dissatisfied with the consultation, share your frustrations with us. Remember—you are the most important person in the room. You are the one who deserves our respect and needs our encouragement. Your future, with you in it alive and well, is our mission. It would be deplorable if mistrust, confusion, or anger festered to the point of hampering your remission or even your peace of mind. In order for success to occur, you and your oncologist must journey together in a partnership of complete honesty. Speak now, tomorrow, and always your mind.

Questions? Call +254 733 994 368 / +254 720 879 630 or E-mail: wecare@pathwayintl.co.ke

Pathway International: providing Global Healthcare Solutions.

The post 7 Tips for a Successful First Visit to Your Oncologist appeared first on Pathway International.

Breast Surgical Oncology – Choosing a Surgeon

Pathway International — Mon, 18 Jun 2018 05:52:25 +0000

Once you have been told that you have breast cancer or might have breast cancer, you will be referred to a surgeon. There are many doctors who perform breast cancer surgery, but most do not specialize in breast cancer. They may just do a handful of cases a year.

We recommend that you choose a breast surgeon who:

Specializes in breast cancer – This demonstrates a commitment and expertise in treating this disease; breast surgeons will be more up to date on the latest surgical techniques than general surgeons who may not focus entirely on breast cancer surgery)
Has done a breast surgical oncology fellowship
Is recognized as a breast surgical oncologist
Performs many breast cancer surgeries each year – High volume surgeons tend to have better results and are more attuned to subtle differences in individual cases. Research shows that patients of breast surgeons who perform a very large volume of breast cancer surgeries have a higher survival rate than patients of lower volume surgeons. Seek out a physician who does 50 or more breast cancer operations a year, and preferably more than 100. It is important to mention that these are breast cancer surgeries (lumpectomies and mastectomies), not breast surgeries. Only breast cancer treatments should be counted in these numbers—not excisional biopsies.

At the Johns Hopkins Avon Foundation Breast Center, our breast surgeons are experts in breast surgical oncology. They work closely with our plastic and reconstructive surgeons to give women the best cosmetic results and options. Our specialists have a greater than 90 percent rate of performing successful breast conservation surgery for patients who meet the criteria for lumpectomy—which saves a woman’s breast(s) and gives her an equal survival rate when compared to women who chose a mastectomy. We also offer nipple sparing and skin sparing mastectomy for patients who meet specific pathology criteria.

State-of-the-Art Surgery with Minimal Pain and Nausea

Our breast surgical oncologists and anesthesiologists have pioneered improvements in surgical and anesthesia management along with other post-surgical care to minimize the nausea and vomiting rate for breast cancer patients. The nausea rate at some breast centers is as high as 85 percent. We have reduced our nausea rate to 1 percent for patients having lumpectomy or mastectomy without simultaneous reconstruction or lumpectomy surgery. This fosters a quicker recovery; the majority of our patients who have breast cancer surgery without reconstruction feel so physically well after surgery that they choose to go home that same day.

Post-Treatment Care

Patients and their family members are instructed in post-treatment wound care. There are special circumstances when arrangements are made for a home health care nurse to visit the patient’s home that evening and the next morning, although this is rarely needed. A nurse practitioner from the Breast Center is in constant contact with the patient for updates. It is the patient’s decision whether to return home the day of surgery. If she does, her pain will be well controlled with oral medications so she’s nausea-free and able to concentrate on her emotional well-being. Any time a patient can avoid hospitalization, risk of infection is reduced and faster healing is possible. She can also return to normal daily activities sooner.

Women having lumpectomy surgery may be ready to go home after being in the recovery room for one to two hours. We have studied how well our patients feel post-operatively and more than 50 percent feel well enough to go out to lunch or dinner that evening to celebrate completing the treatment. This is a testament that they are nausea-free and ready to embrace life again.

Questions? Call +254 718 994368 / 733 994368 or E-mail wecare@pathwayintl.co.ke

PATHWAY INTERNATIONAL: providing Global Healthcare Solutions.

The post Breast Surgical Oncology – Choosing a Surgeon appeared first on Pathway International.